Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Phathom Pharmaceuticals (PHAT) Shares Issued: 2022-2025

Historic Shares Issued for Phathom Pharmaceuticals (PHAT) over the last 2 years, with Sep 2025 value amounting to $293,000.

  • Phathom Pharmaceuticals' Shares Issued rose 3.90% to $293,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 100.41%. This contributed to the annual value of $1.6 million for FY2024, which is 88.64% down from last year.
  • Per Phathom Pharmaceuticals' latest filing, its Shares Issued stood at $293,000 for Q3 2025, which was up 100.05% from -$543.2 million recorded in Q2 2025.
  • Phathom Pharmaceuticals' 5-year Shares Issued high stood at $543.3 million for Q1 2025, and its period low was -$543.2 million during Q2 2025.
  • For the 3-year period, Phathom Pharmaceuticals' Shares Issued averaged around -$50.7 million, with its median value being $287,500 (2024).
  • As far as peak fluctuations go, Phathom Pharmaceuticals' Shares Issued tumbled by 42,148,000.00% in 2024, and later increased by 3.90% in 2025.
  • Over the past 4 years, Phathom Pharmaceuticals' Shares Issued (Quarterly) stood at -$24.6 million in 2022, then reached $1,000 in 2023, then plummeted by 42,148,000.00% to $1.3 million in 2024, then rose by 3.90% to $293,000 in 2025.
  • Its last three reported values are $293,000 in Q3 2025, -$543.2 million for Q2 2025, and $543.3 million during Q1 2025.